{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-031488","form_type":"8-K","ticker":null,"cik":"0001584751","company_name":"Talis Biomedical Corp","filed_at":"2023-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.435617+00:00","generated_at":"2026-06-13T12:41:32.217831+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Talis Biomedical effects 1-for-15 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split effective July 5, 2023; shares reduce from ~26.9M to ~1.8M.","Stock begins trading on post-split basis on Nasdaq on July 6 under symbol TLIS.","No fractional shares; any fractional interest rounded up to one whole share.","CUSIP number changed to 87424L207; par value unchanged at $0.0001.","Split intended to raise per-share price to satisfy Nasdaq minimum bid requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-031488","json":"https://secwatch.observer/filing/0000950170-23-031488.json","markdown":"https://secwatch.observer/filing/0000950170-23-031488.md","text":"https://secwatch.observer/filing/0000950170-23-031488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1584751/000095017023031488/0000950170-23-031488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1584751/000095017023031488/tlis-20230705.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T12:41:32.217831+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a6b9e0fdd1b09b62e0658bb319fdf975b919051d","claim":"Talis Biomedical Corp: Filed a certificate of amendment to effect a 1-for-15 reverse stock split of common stock (effective 2023-07-05).","evidence_excerpt":"On June 30, 2023, Talis Biomedical Corporation (the “Company”) filed a certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware to effect a 1-for-15 reverse stock split of the shares of the Company’s common stock, par value $0.0001 per share, effective as of 5:00 p.m., Eastern Time, on July 5, 2023","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1584751/000095017023031488/0000950170-23-031488-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-07-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}